Oxford Biomedica plc announced a private placement of 3,382,950 new ordinary shares at an issues price of £14.78 per share for the gross proceeds of £50,000,001 on September 22, 2021. The transaction will include participation from new investor, Serum Life Science. As a part of the transaction, the investor will take 3.9% stake into the company.